These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3129843)

  • 21. The effect of 2'deoxyguanosine on human lymphocyte responses. I. 2'deoxyguanosine enhances T lymphocyte responses.
    Hanglow AC; Lydyard PM
    Clin Exp Immunol; 1985 Mar; 59(3):653-8. PubMed ID: 3872754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of antibiotics on human lymphocyte mitogenesis].
    Rachkov SM; Bekbergenov BM; Korolev PN; Glezer GA
    Antibiotiki; 1981 Jan; 26(1):55-8. PubMed ID: 6971073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stimulation of phosphoinositide turnover is an important but not a sole condition for activation of human T-lymphocyte proliferation by phytohemagglutinin and interleukin 2].
    Korichneva IL; Rudchenko SA; Krasnikova TL; Grigorian GIu; Smirnov VN
    Dokl Akad Nauk SSSR; 1989; 304(1):221-4. PubMed ID: 2544387
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 25. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis.
    Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A
    Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens.
    Girón-González JA; Alvarez-Mon M; Menéndez-Caro JL; Manzano L; Abreu L; Yebra M; Durántez-Martínez A
    Am J Gastroenterol; 1994 May; 89(5):767-73. PubMed ID: 8172154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of cyclosporin A on the immune system.
    Shevach EM
    Annu Rev Immunol; 1985; 3():397-423. PubMed ID: 3933532
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine A modulates the proliferation of T-lymphocyte colony forming cell subpopulations.
    Tice DG; Reinitz ER
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1191-2. PubMed ID: 3274305
    [No Abstract]   [Full Text] [Related]  

  • 30. Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.
    Warren HS; Bezos A
    Immunology; 1987 Jun; 61(2):167-72. PubMed ID: 3496271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester.
    Albert F; Hua C; Truneh A; Pierres M; Schmitt-Verhulst AM
    J Immunol; 1985 Jun; 134(6):3649-55. PubMed ID: 3921610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 34. Deficiency in the biosynthesis of interleukin 2 (IL-2) and functional presence of the IL-2 receptor in lepromatous leprosy.
    Islas-Rodriguez AE; Morales-Ortiz R; Fafutis-Morris M; González-Mendoza A; Ortiz-Ortiz L
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):566-9. PubMed ID: 3116127
    [No Abstract]   [Full Text] [Related]  

  • 35. On the partial suppression of IL-2 receptor expression and the prevention of lectin-induced lymphoblast formation by cyclosporine A.
    Solbach W; Heeg K; Von Steldern DU; Röllinghoff M; Wagner H
    Clin Exp Immunol; 1985 Jun; 60(3):501-8. PubMed ID: 3926357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine inhibits macrophage-mediated antigen presentation.
    Palay DA; Cluff CW; Wentworth PA; Ziegler HK
    J Immunol; 1986 Jun; 136(12):4348-53. PubMed ID: 3486899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell growth factor: purification and interaction with a cellular receptor.
    Robb RJ
    Lymphokine Res; 1982; 1(2):37-43. PubMed ID: 6821402
    [No Abstract]   [Full Text] [Related]  

  • 38. The interaction of auranofin and buthionine sulfoximine blocks activation of human peripheral T lymphocytes.
    Vint IA; Chain BM; Foreman JC
    Cell Immunol; 1993 Nov; 152(1):152-61. PubMed ID: 8242758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
    Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.